AI Science Tracker
EN

AI-assisted preoperative planning improves component sizing accuracy in Oxford unicompartmental knee arthroplasty: a retrospective cohort study with 24-month follow-up.

Affiliation not stated in the reviewed material · 30 May 2026 · medicine

Discovery

AI-assisted preoperative planning improves component sizing accuracy in Oxford unicompartmental knee arthroplasty: a retrospective cohort study with 24-month follow-up.

Source check: Source checked. Not independent scientific confirmation.

Finding: Specific clinical planning accuracy result measured against operative sizing; retrospective cohort qualifies narrowly. Do not imply improved patient outcomes; modest HSS difference and single-center/nonrandomized design are material limits.

Technology: 190 knees (AI-assisted n=94, conventional n=96), 3D patient-specific CT bone model and deep-learning landmarks used in preoperative sizing plan; postoperative component size compared with intraoperative sizing. Femoral accuracy 77/94 (81.91%), tibial 80/94 (85.12%), both 66/94 (70.21%). HSS difference 3.18 at 24 months is modest and retrospective nonrandomized design does not establish clinical benefit.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
190 knees (AI-assisted n=94, conventional n=96), 3D patient-specific CT bone model and deep-learning landmarks used in preoperative sizing plan; postoperative component size compared with intraoperative sizing. Femoral accuracy 77/94 (81.91%), tibial 80/94 (85.12%), both 66/94 (70.21%). HSS difference 3.18 at 24 months is modest and retrospective nonrandomized design does not establish clinical benefit.
Test and result
190 knees (AI-assisted n=94, conventional n=96), 3D patient-specific CT bone model and deep-learning landmarks used in preoperative sizing plan; postoperative component size compared with intraoperative sizing. Femoral accuracy 77/94 (81.91%), tibial 80/94 (85.12%), both 66/94 (70.21%). HSS difference 3.18 at 24 months is modest and retrospective nonrandomized design does not establish clinical benefit.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study; author affiliation is not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s13018-026-06935-9

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.